Harpoon Therapeutics Inc expected to post a loss of 44  cents a share - Earnings Preview

Harpoon Therapeutics

04/05/2021 18:50

* Harpoon Therapeutics Inc  HARP.OQ   HARP.O  is expected to
show a rise in quarterly revenue when it reports results on May
4 (estimated).
* The South San Francisco, California-based company is expected
to report   a 100.3% increase in revenue to $6.605 million from
$3.3 million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data.
​* Refinitiv's mean analyst estimate for Harpoon Therapeutics
Inc is for a loss of 44 cents per share. For the same quarter
last year, the company reported a loss of 51 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $31​, about 25% above​ its last closing
price of $23.25. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.48       -0.54      -0.45     Beat    16.7
 Sep. 30 2020  -0.47       -0.50      -0.53     Missed  -7
 Jun. 30 2020  -0.48       -0.47      -0.51     Missed  -7.4​
 Mar. 31 2020  -0.36       -0.41      -0.51     Missed  -23.5
 Dec.          -0.48​      -0.53      -0.58     Missed  -9.5​
 31​ 2019​                                              
 Sep. 30 2019  -0.55       -0.55      -0.65     Missed  -18.1​
 Jun. 30 2019  -0.63       -0.63      -0.49     Beat    22.5
 Mar. 31 2019  -0.44       -0.44      -0.92     Missed  -107.9
 This summary was machine generated May 4 at 17:49 GMT.  All
figures in US dollars unless otherwise stated